On-Demand Webinar Archive
To access the archived recording of this webinar, visit our webinar channel and complete a one time only form. This will give you access to our entire library of archived webinars.Download Now
Orphan drug development has several unique challenges. This webinar provides expert guidance and case studies to help address the major challenges of patient engagement and retention during the study.
Download this webinar to:
- Understand patient-based clinical trial designs that are scientifically robust and address the unique challenges of rare disease
- Understand rare disease patient concerns about clinical trial participation
- Practical strategies for patient engagement, recruitment and retention during rare disease trials.
William Maier, MD, PhD
Chief Scientific Officer & Head, Rare Disease Research, Commercialisation and Outcomes, ICON
Dr. Maier has over 25 years of experience in drug development and commercialisation at pharmaceutical companies in Europe, Canada, the United States and Asia. In his current role he works with pharmaceutical companies throughout the world to provide regulatory, strategic and scientific guidance on medical treatment development and commercialisation. He is a member of the EMEA’s European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (www.encepp.eu). In addition, he is a frequent speaker at medical conferences, has had academic appointments in the UK (Dundee) and the USA (North Carolina) and is a member of the Royal Society of Medicine in the UK.
Global Head, Patient Recruitment and Retention Solutions, ICON
Gretchen leads the Patient Recruitment and Retention Solutions group at ICON working with a team of strategists to implement recruitment and retention programs on all pertinent ICON studies. Their focus is on protocol-specific support solutions and patient engagement strategies for enrolment and beyond, resulting in a more a more holistic, patient-centric approach. The team focuses on building patient, caregiver and site awareness, as well as education of the disease and study.
Gretchen has amassed over 20 years of clinical research experience, including the start of her career as a study coordinator and then as a Site Director at the University of Pennsylvania in various therapeutic areas including ophthalmology, women's health, HIV/AIDS, cardiology and endocrinology. Most recently Gretchen was the Senior Director of the Patient Access and Retention group at PRA. Prior to that, she was the Patient Recruitment and Retention Strategist at Sanofi-Aventis, where her focus was all U.S. Phase II-IV clinical studies. Prior to that she served as a Clinical Trial Manager at Wyeth in the Global Medical Affairs vaccines group and Astra Zeneca as a study manager in the cardiovascular group.